Evidence map›Paper›PMID 41432414›Full record

ArticleJournal of neurochemistry2025

Postnatal Mouse Brain Region-Resolved Peptidomic Resource of Conditional Ndel1 Loss: Comparison of Acidic and Alcoholic Extraction Strategies.

João V Nani, Jackelinne Yuka Hayashi, Joana D Campeiro, Guilherme Araújo Câmara, Atsushi Saito, William Y Oyadomari, Akira Sawa, Atsushi Kamiya, Alexandre K Tashima, Mirian A F Hayashi

Abstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

João V NaniDepartment of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.ORCID 0000-0002-4336-1709
Jackelinne Yuka HayashiDepartment of Biochemistry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Joana D CampeiroDepartment of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Guilherme Araújo CâmaraDepartment of Biochemistry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Atsushi SaitoDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
William Y OyadomariDepartment of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Akira SawaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Atsushi KamiyaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alexandre K TashimaDepartment of Biochemistry, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Mirian A F HayashiDepartment of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Funding

Project 3P50MH136297 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Akira Sawa · 2024 to 2026
$12.8M
Microglia-mediated adverse effect of cannabis on prefrontal cortex maturation and cognitive functionR01DA060630 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Atsushi Kamiya · 2025 to 2026
$1.4M
Atsushi Kamiya DA060630Atsushi Kamiya MH136297Conselho Nacional de Desenvolvimento Científico e Tecnológico 310057/2023-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 39337/2016-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Financial Code 001Financiadora de Estudos e Projetos 04.16.0054.02Fundação de Amparo à Pesquisa do Estado de São Paulo 2011/50963-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/50891-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/02413-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/08287-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/09207-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/13112-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/01107-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/00527-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/03297-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/07904-4NIDA NIH HHS R01 DA060630NIMH NIH HHS P50 MH136297
6 · The paper itself

Abstract

The oligopeptidase Ndel1 (NudE neurodevelopment protein 1 like 1) is a multifunctional protein implicated in neurodevelopmental processes, intensively investigated as a potential biomarker in psychiatric disorders. While its roles in regulating the cytoskeleton are well-studied, the global consequences of its loss on the brain's peptide landscape are unknown. This study presents a comprehensive, region-resolved peptidomic resource detailing the consequences of postnatal Ndel1 loss in the mouse cortex, hippocampus, striatum, and cerebellum. We also validated this method of microwave protease inactivation followed by acidic and organic extractions by means of this peptidome analysis across several brain regions. More specifically, using a conditional knockout mouse model with Ndel1 deletion in forebrain excitatory neurons, we employed complementary acidic and alcoholic extraction workflows coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS). We generated a comparative atlas of differentially abundant peptides (DAPs), identifying hundreds of peptide changes across the different brain regions and extraction methods. Gene Ontology analysis of the inferred source proteins revealed alterations in pathways related to cytoskeletal organization, synaptic function, and cellular metabolism. This dataset provides a foundational resource for generating new hypotheses about Ndel1's region-specific functions and serves as a valuable reference for the neurodevelopmental and neuropeptidomics communities. Understanding these Ndel1-driven changes is crucial, providing valuable insights into the pathophysiology of neurodevelopmental and mental disorders linked to reduced Ndel1 activity, such as schizophrenia, autism, and bipolar disorder. This holistic view may reveal novel therapeutic targets for these complex conditions.

Indexed as

BrainCarrier ProteinsAnimalsAnimals, NewbornChromatography, LiquidFemaleMaleMiceMice, Inbred C57BLMice, KnockoutProteomicsTandem Mass SpectrometryCarrier Proteinsbrain protein expressionconditional knockoutcytoskeletal proteinsmass spectrometryNdel1peptidomeprotein–protein interactionproteostasis

Identifiers

PMID41432414
PMCPMC12724395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.